In recent years, Escherichia coli has served as one of a few model bacterial species for studying cyclic di-GMP (c-di-GMP) signaling. The widely used E. coli K-12 laboratory strains possess 29 genes encoding proteins with GGDEF and/or EAL domains, which include 12 diguanylate cyclases (DGC), 13 c-di-GMP-specific phosphodiesterases (PDE), and 4 "degenerate" enzymatically inactive proteins. In addition, six new GGDEF and EAL (GGDEF/EAL) domain-encoding genes, which encode two DGCs and four PDEs, have recently been found in genomic analyses of commensal and pathogenic E. coli strains. As a group of researchers who have been studying the molecular mechanisms and the genomic basis of c-di-GMP signaling in E. coli, we now propose a general and systematic dgc and pde nomenclature for the enzymatically active GGDEF/EAL domain-encoding genes of this model species. This nomenclature is intuitive and easy to memorize, and it can also be applied to additional genes and proteins that might be discovered in various strains of E. coli in future studies.
M
ore than 10 years ago, it was demonstrated that GGDEF domains can produce and EAL domains can degrade the bacterial second messenger cyclic di-GMP (c-di-GMP) (1) (2) (3) (4) . With these assignments, it also became clear that bacterial genomes-in particular, those of gammaproteobacteria-usually contain multiple genes encoding these diguanylate cyclases (DGC) and c-di-GMP phosphodiesterases (PDE) (5, 6) . Crystal structures of GGDEF and EAL domains have been elucidated, and studies of structure-function relationships have identified the key amino acid residues required for substrate and cation binding and catalysis (7) . This also allowed identification of a subset of GGDEF and EAL (GGDEF/EAL) domain proteins, in which these key amino acids are not conserved, as "degenerate" and enzymatically inactive. In a few cases, it could be demonstrated that these degenerate GGDEF/EAL domain proteins have alternative functions based on direct interactions with other macromolecules (8) (9) (10) (11) . A subset of proteins combine GGDEF and EAL domains in a single polypeptide, where one domain is usually enzymatically active and the other is degenerate and plays a regulatory role in these "composite" proteins (3). Most GGDEF/EAL domain proteins also contain N-terminal sensory input domains that control their output activities, and a majority are localized or anchored in the cytoplasmic membrane via their membrane-intrinsic or periplasmic sensory domains (12).
In studies of the molecular principles and physiological functions of c-di-GMP signaling, Escherichia coli has served as one of a few model species (13, 14) . The commonly used E. coli K-12 laboratory strain has a total of 29 proteins with GGDEF and/or EAL domains, including 12 and 10 proteins featuring the GGDEF and EAL domains alone, respectively, and 7 composite proteins carrying both domains. Based on direct measurements of purified proteins and/or the presence of key conserved amino acids and their elimination by point mutations, DGC and PDE activities can be assigned to 12 and 13 proteins, respectively, whereas 4 of the 29 proteins can be classified as degenerate GGDEF/EAL proteins (Table 1) . Genes involved in c-di-GMP signaling have also been studied in pathogenic E. coli, i.e., in uropathogenic E. coli (UPEC) (42) , and two additional genes encoding PDEs have been detected in an enterohemorrhagic E. coli (EHEC) strain (38) and a meningitis-associated E. coli strain (39) . Together with a recent analysis of genome sequences of 61 E. coli strains (29) , which included commensal as well as pathogenic strains of the major pathotypes and phylogroups, a total of two additional GGDEF domain proteins and four more EAL domain proteins have been identified that are not found in E. coli K-12. On the basis of the presence of the key residues involved in enzymatic activities, these proteins should be active DGCs and PDEs (see an accompanying paper [29] in this issue).
Being aware that a systematic nomenclature of the many E. coli genes encoding DGCs and PDEs might eventually be useful, most researchers have refrained from renaming single genes and proteins involved in c-di-GMP signaling in E. coli and have used the preliminary y designations instead, even though these were difficult to memorize and certainly not popular in oral scientific presentations. However, on the basis of the finding that the DGC YdeH is regulated by zinc, it was recently renamed "DgcZ" (23) . Also, the newly identified genes encoding DGCs and PDEs in non-K-12 E. coli strains had to be given names, and it seemed obvious to use a dgc and pde nomenclature (29) .
Therefore, as a group of researchers who in recent years have worked on the molecular mechanisms and/or the genomic basis of c-di-GMP signaling in E. coli, we now propose a general and systematic dgc and pde nomenclature for the enzymatically active GGDEF/EAL domain-encoding genes of E. coli (Table 1) . By using these self-explanatory designations, we also reflect a trend for similar (though not yet systematically used) names for GGDEF/EAL domain proteins in some other species, including Caulobacter, Pseudomonas, Listeria, and Bdellovibrio spp. We are fully aware that nomenclature is a convention and sometimes has to include oversimplifications (for instance, for proteins with multiple functions), but its main function is to allow researchers to remember things and communicate more easily. In detail, the proposed nomenclature is based on the following considerations. • Following the principle that genes should be named according to the molecular function of the gene product and not according to a mutant phenotype that may be due to a very indirect connection and may represent a functional side effect, "dgc" and "pde" designations are based either on experimentally determined DGC and PDE activities or on the presence of the conserved key amino acids required for these enzymatic functions. These conserved amino acids include the (G/A/S)G(D/E)EF motif in DGCs (43, 44) and the presence of the catalytic glutamyl residue and the main amino acids involved in c-di-GMP and cation binding in PDEs (45) (46) (47) . The latter criterion reflects pragmatic reasons of feasibility-while isolated and usually soluble EAL domains alone often show PDE activity in vitro, isolated GGDEF domains are usually inactive, which makes measuring DGC activity of membrane-associated DGCs rather challenging. Not only should sensory input domains be integrated into an appropriately reconstituted lipid environment to allow dimerization of the GGDEF domains as a prerequisite for enzymatic activity, but these sensory domains might also need to bind as-yet-unknown ligands in order to promote enzymatic activity.
• The seven composite proteins with both GGDEF and EAL domains can be unequivocally assigned DGC or PDE functions and therefore the corresponding gene designations. In six of the seven cases, one of the two domains is clearly degenerate (Table 1) . Only YciR features intact GGDEF and EAL domains, but it has been demonstrated that, in this case, the purified protein shows strong PDE activity in vitro (19, 20) , whereas its GGDEF domain binds GTP but has only very minor and, in fact, cryptic DGC activity (20) . We therefore propose pdeR as a new gene designation for yciR, with the "R" also seeming appropriate because PdeR is the core component of a regulatory switch that controls the expression of the CsgD major biofilm regulator in E. coli. Thus, PdeR is a multifunctional "trigger protein," whose ability to bind and degrade c-di-GMP plays a regulatory role as it modulates the direct inhibitory interactions of PdeR with the transcription factor complex that controls csgD expression (20) .
• In order to make the transition to the systematic nomenclature easier for people who have been working with these genes and proteins of E. coli, we propose to retain the capital letter currently found in the y designations (e.g., ydaM becoming dgcM, etc.) in as many cases as possible. There is only a single case of overlap-we suggest that yfeA should be renamed pdeA but that yahA should be renamed pdeL (referring to its N-terminal LuxR domain). In the case of ydeH, dgcZ, which alludes to the zinc binding of the sensory domain of the gene product, has already been introduced (23) .
• In the few cases where genes are in operons, we propose to use the same capital letter; i.e., we propose that yliF and yliE should become dgcI and pdeI and that ycdT and a pde gene that follows ycdT in certain EHEC strains should become dgcT and pdeT.
• For a few already renamed genes (e.g., genes dosC and dosP and genes vmpA and sfaY), we suggest retaining these names as alternative designations but also reserving systematic names (e.g., genes dgcO and pdeO and genes pdeT and pdeY, respectively) and leaving it to the researchers working with these genes to determine which designation they want to use (for clarity, we suggest also mentioning the other designations in future publications). In addition, Table 1 also includes a few established designations for corresponding homologs in other bacterial species.
• Among the four genes encoding proteins with degenerate GGDEF/EAL domains only, yeaI is the only one that encodes a protein that binds c-di-GMP (F. Skopp and R. Hengge, unpublished data), indicating that this protein serves as a c-di-GMP-binding effector. We therefore propose cdgI as a new designation. For the other three genes, which encode proteins that do not bind c-di-GMP, we suggest that the previously assigned designations that reflect the functions of the encoded proteins should be retained. Thus, ycgF was already renamed bluF (alluding to its blue-light sensing BLUF domain) (9, 40) and yhdA was renamed csrD (as it controls the CsrA/CsrB/CsrC system) (8) . Degenerate EAL-only protein YdiV was shown to directly inhibit and promote proteolysis of the flagellar master regulator FlhDC (10, 11) , and we therefore propose rflP (regulator of FlhDC proteolysis) as a new gene name.
Besides assigning new systematic names to the genes and proteins involved in c-di-GMP signaling in E. coli, we also use this opportunity to introduce systematic designations for several Nterminal sensory input domains present in some of these proteins that have not been described before (Table 1 ). In particular, these are (i) two novel MASE (membrane-associated sensor) domains, i.e., MASE4, an eight-transmembrane helix domain found in DgcX and DgcT (YcdT) and the degenerate c-di-GMP-binding protein CdgI (YeaI) (18, 29) , and MASE5, a six-transmembrane helix domain present in DgcY (29); (ii) four distinct "GAPES" domains (referring to gammaproteobacterial periplasmic sensory domains), which occur in DgcJ (YeaJ), DgcI (YliF), PdeK (YhjK), and CsrD; and (iii) three novel CHASE (cyclases/histidine kinaseassociated sensory) domains present in DgcQ (YedQ), DgcN (YfiN), and PdeI (YliE). In contrast to CHASE domains, GAPES domains seem to be restricted to GGDEF/EAL domain proteins. The molecular functions in c-di-GMP signaling of all of these sensory input domains have yet to be elucidated.
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